Follow CGSP on Social Media

Listen to the CGSP Podcast

The Mideast’s Travel and Hospitality Industry Has a Lot at Stake in the WHO’s Impending Ruling on Chinese Vaccines


Representatives from the Mideast’s travel industry are closely watching their news feeds for any updates on the World Health Organization’s impending decision as to whether or not to grant emergency use approval to Chinese-made COVID-19 vaccines Sinopharm and Sinovac.

Currently, the European Union will only permit tourists from outside the bloc who’ve been inoculated with an approved vaccine. Travel industry leaders in the Persian Gulf and Mideast regions are hopeful Brussels will soon extend that to also include jabs validated by the WHO as well — and given the widespread use of Sinopharm in the region, that could potentially be the catalyst to get people traveling again between EU and GCC countries.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.